NCT05521828View on ClinicalTrials.gov

Luteal Phase Ovarian Stimulation With Follitropin Delta and Dydrogesterone

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions
Oocyte DonorsOocyte Donation
Interventions
DRUG

Follitropin delta (Rekovelle)

12 mcg/day will be used for ovarian stimulation in both arms

DRUG

Duphaston

20 mg/day will be used for pituitary suppression in both arms

DRUG

GnRH agonist (Gonapeptyl)

(2 ampules:0.2 mg) will be used for ovulation triggering in both arms

Trial Locations (1)

1090

RECRUITING

Brussels Ivf, Brussels

All Listed Sponsors
lead

CRG UZ Brussel

OTHER